CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 148,901 Value ($000) $7,808 Avg Close $59.89 Range $48.02 - $78.48

Q2 2025

Shares 964,690 Value ($000) $46,923 Avg Close $38.70 Range $30.04 - $51.52

Q1 2025

Shares 1,952,751 Value ($000) $66,452 Avg Close $42.39 Range $32.96 - $55.88

Q4 2024

Shares 690,191 Value ($000) $27,166 Avg Close $47.22 Range $38.20 - $59.07

Q3 2024

Shares 676,326 Value ($000) $31,774 Avg Close $50.74 Range $43.42 - $63.68

Q2 2024

Shares 693,958 Value ($000) $37,481 Avg Close $57.84 Range $51.02 - $68.39

Q1 2024

Shares 110,465 Value ($000) $7,529 Avg Close $71.59 Range $58.29 - $91.10

Q4 2023

Shares 95,950 Value ($000) $6,006 Avg Close $55.02 Range $37.55 - $76.97

Q3 2023

Shares 93,125 Value ($000) $4,227 Avg Close $51.65 Range $44.53 - $59.67

Q2 2023

Shares 82,286 Value ($000) $3,722 Avg Close $56.74 Range $43.10 - $72.00

Q1 2023

Shares 82,286 Value ($000) $3,722 Avg Close $48.57 Range $39.88 - $58.50

Q4 2022

Shares 75,906 Value ($000) $3,086 Avg Close $53.05 Range $38.94 - $66.31

Q3 2022

Shares 75,786 Value ($000) $4,952,615 Avg Close $72.47 Range $60.41 - $86.95

Q2 2022

Shares 133,154 Value ($000) $8,091,770 Avg Close $58.79 Range $42.51 - $75.42

Q1 2022

Shares 119,327 Value ($000) $7,490,156 Avg Close $62.79 Range $50.54 - $79.40

Q4 2021

Shares 119,533 Value ($000) $9,058,212 Avg Close $87.36 Range $67.15 - $112.39

Q3 2021

Shares 114,420 Value ($000) $12,807,032 Avg Close $125.59 Range $109.63 - $163.00

Q2 2021

Shares 117,213 Value ($000) $18,975,612 Avg Close $121.62 Range $95.11 - $169.76

Q1 2021

Shares 141,054 Value ($000) $17,187,429 Avg Close $151.00 Range $100.00 - $220.20

Q4 2020

Shares 106,746 Value ($000) $16,343,881 Avg Close $118.20 Range $79.31 - $181.42

Q3 2020

Shares 120,592 Value ($000) $10,086,316 Avg Close $88.70 Range $74.00 - $105.12

Q2 2020

Shares 139,030 Value ($000) $10,217,314 Avg Close $58.47 Range $38.10 - $79.92

Q1 2020

Shares 130,328 Value ($000) $5,527,211 Avg Close $51.63 Range $32.30 - $64.19

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	148,901	$7,808	$59.89	$48.02 - $78.48
Q2 2025	964,690	$46,923	$38.70	$30.04 - $51.52
Q1 2025	1,952,751	$66,452	$42.39	$32.96 - $55.88
Q4 2024	690,191	$27,166	$47.22	$38.20 - $59.07
Q3 2024	676,326	$31,774	$50.74	$43.42 - $63.68
Q2 2024	693,958	$37,481	$57.84	$51.02 - $68.39
Q1 2024	110,465	$7,529	$71.59	$58.29 - $91.10
Q4 2023	95,950	$6,006	$55.02	$37.55 - $76.97
Q3 2023	93,125	$4,227	$51.65	$44.53 - $59.67
Q2 2023	82,286	$3,722	$56.74	$43.10 - $72.00
Q1 2023	82,286	$3,722	$48.57	$39.88 - $58.50
Q4 2022	75,906	$3,086	$53.05	$38.94 - $66.31
Q3 2022	75,786	$4,952,615	$72.47	$60.41 - $86.95
Q2 2022	133,154	$8,091,770	$58.79	$42.51 - $75.42
Q1 2022	119,327	$7,490,156	$62.79	$50.54 - $79.40
Q4 2021	119,533	$9,058,212	$87.36	$67.15 - $112.39
Q3 2021	114,420	$12,807,032	$125.59	$109.63 - $163.00
Q2 2021	117,213	$18,975,612	$121.62	$95.11 - $169.76
Q1 2021	141,054	$17,187,429	$151.00	$100.00 - $220.20
Q4 2020	106,746	$16,343,881	$118.20	$79.31 - $181.42
Q3 2020	120,592	$10,086,316	$88.70	$74.00 - $105.12
Q2 2020	139,030	$10,217,314	$58.47	$38.10 - $79.92
Q1 2020	130,328	$5,527,211	$51.63	$32.30 - $64.19